A carregar...
Delamanid expanded access novel treatment of drug resistant tuberculosis
Tuberculosis (TB) remains a global emergency and is one of the most common infectious disease causes of death in developing countries. Current treatment regimens for multi-drug resistant TB are associated with low treatment success rates, are toxic, and require long duration of treatment. The need f...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4631416/ https://ncbi.nlm.nih.gov/pubmed/26604805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S62119 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|